In this study, we recruited 161 DLBCL cases in our hospital, among whom patients with the NOTCH1 mutation had a lower complete response rate than patients without the NOTCH1 mutation. This evidence concerns the gene NOTCH1 and diffuse large B-cell lymphoma.